The cytotoxicity induced by either CAR T cell construct against SK-N-BE(2) neuroblastoma cells (lacking functional TP53) was unchanged by SP-2509 pretreatment, supporting that TP53-dependent FAS upregulation is the reason for enhanced CAR T cell efficacy. Here, FAS is linked to neuroblastoma.